New shot in the fight against shingles: vaccine trial seeks to prevent painful nerve condition

NCT ID NCT06932523

Summary

This study is testing a new shingles vaccine to see if it is safe and if it helps the body build protection against the virus. It will involve about 645 healthy adults aged 40 and older, who will receive two shots. Researchers will compare the new vaccine to an already approved shingles vaccine and a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HERPES ZOSTER (HZ) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hubei Provincial Center for Disease Control and Prevention

    RECRUITING

    Wuhan, Hubei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.